Becton, Dickinson and Company (NYSE:BDX) authorized to pursue a plan to separate BD’s Biosciences and Diagnostic Solutions ...

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled ...

Becton Dickinson said it would focus on medtech and prioritize research, acquisitions and high-growth markets.

Activist investor Starboard Value is urging Becton Dickinson to sell its life sciences division, citing potential value gains. Analysts estimate a spin-off could boost the company's worth by up to 30% ...

Chief Executive Tom Polen said he believes the separation would help differentiate BD in the medical-technology industry, and ...

The Financial Times had earlier reported that activist investor Starboard Value had taken a stake in Becton and was pushing ...

Not-for-profit healthcare organisation Carilion Clinic is set to provide needle-free blood draws to patients leveraging ...

Becton Dickinson is expanding production of medical ... has already added new needle and syringe production lines at its plants in Connecticut and Nebraska. One of those lines is fully operational ...

Becton Dickinson (NYSE:BDX) said it plans to make additional investments in its U.S. manufacturing network to add capacity for the production of critical medical devices such as syringes, needles ...